Navigation Links
Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
Date:11/19/2007

mune disease, meaning that the body confuses healthy tissue for foreign substances and attacks itself. The cause is unknown. The disease often begins with fatigue, morning stiffness, weakness and muscle aches. Eventually, joint pain appears. Pain may affect the wrists, knees, elbows, fingers, toes, ankles or neck. Other symptoms may include anemia, eye burning, limited range of motion, skin redness and swollen glands. Joint destruction may occur within 1 to 2 years after the disease appears. Some cases cause deformities. Treatment typically begins with medications but may include physical therapy and surgery.

Among other findings in the report:

-- Combining prednisone with the synthetic DMARD hydroxychloroquine, methotrexate or sulfasalazine works better than using only a synthetic DMARD to reduce joint swelling and tenderness and to improve function.

-- No meaningful clinical differences can be found between methotrexate and either leflunomide or sulfasalazine.

-- Combining the synthetic DMARDs methotrexate and sulfasalazine is no more effective than using just one of the medications for patients with early rheumatoid arthritis.

-- Not enough evidence exists to determine whether combining two biologic DMARDs is more effective than using one biologic DMARD.

-- About 17 of every 1,000 people taking a biologic DMARD for 3 to 12 months have a serious infection. Combining two biologic DMARDs can increase the risk.

-- Among biologic DMARDs, rates of painful injection site reactions are more common for anakinra (67 percent) than for etanercept (22 percent) or adalimumab (18 percent).

-- More long-term research is needed on rheumatoid arthritis medications, including how the outcomes of these drugs vary among patients with different health conditions and demographic characteristics. More comparative studies on various combinations of drugs are critical. Also important is investigating whether taking the medications ea
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
2. Diet and medications may assist prevention of prostate cancer
3. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
4. Patients cant recall their medications to tell doctors
5. The American Pharmacists Association Supports Consumer Education About OTC Medications
6. For Health Info, Women Often Turn to the Web
7. Doctors Often Miss High Blood Pressure in Kids
8. One Surgery Often Enough for Peritonitis
9. Gene Studies of Male-Female Differences Often Flawed
10. Melanoma Diagnosis Often Delayed for Rural Poor
11. Drinking Often Spurs Move to Poorer Neighborhoods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Ethiopia (PRWEB) , ... July 28, 2015 , ... ... during U.S. President Barack Obama’s visit to Ethiopia to learn more about the ... the Future Initiative . This initiative focuses on accelerating agricultural development as an ...
(Date:7/28/2015)... ... July 28, 2015 , ... opaJUMP! and O-PA! Performance ... health outcomes associated with its training methods. This company is also the first ... study, conducted in early 2015, training yielded an average 80% improvement in functional ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic ... returns skin to a smooth state, and reduces the appearance of fine lines and ... only FDA-approved injectable gel to instantly add volume to your cheek area to correct ...
(Date:7/28/2015)... ... July 28, 2015 , ... Bipolar disorder is often associated with ... a few times a year. The World Health Organization (WHO) has reported that bipolar ... of Mental Health reveals that the United States has the highest lifetime rate of ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese ... than they are in the general population. Surviving Mesothelioma has just posted an ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2
... HealthDay Reporter , FRIDAY, June 24 (HealthDay News) -- Autism ... engineers and computer programmers who have autistic children compared to, ... to those observations. Researchers from Cambridge University in England ... with an autism spectrum disorder in a region of the ...
... News) -- Snacking accounts for 25 percent of the calories ... of those snacking calories, a new study indicates. Since ... that averages 580 calories per day, said Richard D. Mattes, ... West Lafayette, Ind. Because many Americans don,t think about ...
... thousands of tiny worms and a homegrown invention to ... Disease. A team of researchers from the faculties ... $450,000 grant from the Collaborative Health Research Projects program, ... to search for effective new drugs to treat the ...
... , FRIDAY, June 24 (HealthDay News) -- Among U.S. drivers ... positive for drugs, a new study has found. Most commonly, ... such as cocaine and amphetamines, and each of these drugs accounted ... in the July issue of the Journal of Studies on ...
... study confirms that medications with anticholinergic activity, which include ... impairment. The research is also the first to identify ... over-the-counter and prescription sleep aids and incontinence treatments ... the impact of these medications on 13,000 men and ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- ... salad dressing appeal to many, but new evidence indicates that ... foods and that those who can,t may end up eating ... presented at the 2011 Institute of Food Technologists annual meeting ...
Cached Medicine News:Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Drug Use May Play Role in 25% of Driver Deaths, Study Finds 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 3Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3
(Date:7/28/2015)... 28, 2015 Mike Rowe , spokesperson and ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference and ... Las Vegas, Nev. ... Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent ... "unsung heroes" – people whose hard work, sacrifice and value ...
(Date:7/28/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today its results for the second quarter ... Pat Mackin, Chairman, President and Chief Executive Officer, said, ... growth strategy with solid progress on several of our ... transition to a direct sales model in France, advancing ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
...
... contains primers and a FAM-labeled probe that is ... 532-labeled probe to detect Flu B. In addition, ... probe for a separate sample processing control. This ... Alexa 532 and Texas Red reporter dyes such ...
...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: